Cargando…
Familial platelet disorders with a predisposition to acute myelogenous leukaemia: a RUNX1 update
Autores principales: | Rossini, J, Mercorella, B, Townshend, S, Vakulin, C, Rawlings, L, Li, X, Hahn, C, Scott, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326735/ http://dx.doi.org/10.1186/1897-4287-10-S2-A64 |
Ejemplares similares
-
Myelogenic Leukaemia
Publicado: (1915) -
Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia
por: Glembotsky, Ana C., et al.
Publicado: (2019) -
First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: correlation with the clinical phenotype
por: Glembotsky, Ana C., et al.
Publicado: (2020) -
Genetic testing and immunohistochemistry for SDHB in phaeochromocytoma-paraganglioma syndromes: the South Australian experience
por: Poplawski, NK, et al.
Publicado: (2012) -
Immunotherapy for Acute Myelogenous Leukaemia
por: Powles, R. L., et al.
Publicado: (1973)